[ Price : $8.95]
FDA approves a CNS Therapeutics NDA for Gablofen (baclofen injection) for use in managing severe spasticity.[ Price : $8.95]
Federal Register Final rule: FDA approves a Boehringer Ingelheim Vetmedica sNADA for minor label revisions to Dry-Clox Intramammar...[ Price : $8.95]
Federal Register Notice: FDA withdraws approval of Hoffmann-La Roches NDA for Accutane because the product is no longer marketed.[ Price : $8.95]
Daiichi Sankyo and Genzyme file a patent infringement suit against Impax Laboratories over a recently submittied ANDA for a generi...[ Price : $8.95]
Omthera Pharmaceuticals and FDA reach agreement on a special protocol assessment on a planned Phase 3 trial involving Epanova for ...[ Price : $8.95]
FDA approves an Advanced Cell Technology IND to begin a Phase 1-2 multicenter clinical trial using retinal cells derived from huma...[ Price : $8.95]
FDA grants OraSure Technologies an investigational device exemption for the final phase of testing for the OraQuick Rapid HIV-1/2 ...[ Price : $8.95]
Cornerstone Therapeutics voluntarily withdraws three generic opiate propoxyphene products upon FDA request due to new clinical dat...